Clinical trial
Treatment of Bolivian Cutaneous Leishmaniasis With a Combination of Short Courses of Miltefosine and Antimony
NCT01380301 is registered in ClinicalTrials.gov with Foundation Fader as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Bolivian Cutaneous Leishmaniasis With a Combination of Short Courses of Miltefosine and Antimony
- Lead sponsor
- Foundation Fader
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- January 31, 2009
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis